Definitive Contract HHSN266200500028C
Award Date
9/30/05
Potential Completion Date
3/31/11
Potential Value
$19M
Federal Agency
NIAID DEA OA Acquisitions
Ultimate Awardee
Mount Sinai Hospital
NAICS Category
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
New York, NY 10029, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
21
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS), a private university and non-profit educational institution. The $10,799,605.00 Definitive Contract is for BIOMEDICAL (BASIC) services, with a Firm Fixed Price pricing type. The contract has no set-aside designation and was awarded on August 17, 2009, with a completion date of September...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, awarded a $42,132,619.00 definitive contract to the Icahn School of Medicine at Mount Sinai (ISMMS) for the NIAID Centers of Excellence for Influenza Research and Surveillance program. This cost-no-fee contract, awarded on March 30, 2007, has a performance period ending on May 23, 2017. ISMMS, a private university and non-profit organization, will...
This federal contract award is for the "MODELING IMMUNITY FOR BIODEFENSE" program, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS), a private non-profit educational institution. The award is a $23,517,489.00 definitive contract with a cost-no-fee pricing type, with a period of performance from September 29, 2005 to September 29, 2010. The contract does not have a set-aside designation. ISMMS, a renowned...
This federal contract award is to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution in New York City. The contract, valued at $399,266.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to support the development of animal models of infectious diseases. The award is a delivery order under NIAID's larger "Animal Models of Infectious Diseases...
This federal contract award to the Icahn School of Medicine at Mount Sinai (ISMMS) was made by the National Institute of Allergy and Infectious Diseases (NIAID) to conduct research on "Modeling Immunity for Biodefense". The $17,219,467.21 cost-no-fee contract has a period of performance from September 30, 2010 to September 29, 2015 and does not have a set-aside designation. Under this award, ISMMS is collaborating with several subcontractors, including the California Institute of...
This is a $128,680,006.00 definitive, cost no fee federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai. The contract will support the NIAID Centers of Excellence for Influenza Research and Response (CEIRR), a multi-disciplinary collaborative network focused on influenza research. The contract was not set aside for any specific business type. The Icahn School of Medicine at Mount Sinai is a prominent...
This federal contract award, valued at $121,633.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the Icahn School of Medicine at Mount Sinai (ISMMS) for the development of mouse models to support research on low pathogenic seasonal and pandemic influenza viruses. The period of performance is from September 9, 2013, through September 8, 2014, with a final completion date of May 8, 2015. This award is a delivery order under the NIAID Animal Models of...
This is a firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the Icahn School of Medicine at Mount Sinai (ISMMS) to provide animal models for infectious disease research. The contract is a delivery order under the larger NIAID Animal Models of Infectious Diseases 2010-2017 Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle. The award has a ceiling value of...
This is a prime contract award by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the Icahn School of Medicine at Mount Sinai. The contract is for the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) program, which focuses on influenza virus research and surveillance. The contract has a potential value of $182,225,040.82 and does not utilize any set-aside designations. As the prime contractor,...
This is a definitive contract awarded by the Department of the Army's Research, Development and Engineering Command (RDECOM) to the Icahn School of Medicine at Mount Sinai (ISMMS), a renowned academic medical center and research institution located in New York City. The contract, valued at $1,041,139.74, was awarded on February 1, 2024, and has a completion date of February 28, 2025. The purpose of this contract is to develop and standardize an assay for evaluating immunomodulatory activities of...